• Search

  • Post Date

  • Categories

  • Contributors

Fundamental Concepts of Study Design

By Ambuj Kumar, MD

April 17th, 2018

Dr. Kumar relates some of the basic concepts behind medical study design, enabling the listener to utilize simple tools to be able to review the medical literature with a critical eye. He also addresses the question, “What constitutes BEST evidence?” Dr. Kumar also reviews basic statistical concepts, including prevalence/pre-test probability, sensitivity and specificity, negative and positive predictive value, likelihood ratios, and post-test probability. The talk is a very easily understandable and relatable discussion of evidence-based medicine.

Antibiotic Stewardship and Superbugs

By Daniel Haight, MD, FACP

April 16th, 2018

Dr. Daniel Haight, Associate Professor at the USF College of Medicine, and Vice President of Community Health with Lakeland Regional Health, presents a primer on ways to foster and enhance antibiotic stewardship efforts in your hospital or health care system. Presented to the northern Iceland clinics and hospital in Akureyri, Iceland in April, 2018.  The presentation features English narration with Icelandic/English slide content. Part of IDPodcast’s international podcast series.

Pneumocystis Jirovecii Pneumonia (PCP): The Non-HIV-infected Patients

By Yanina Pasikhova, Pharm.D.

April 9th, 2018

Dr. Pasikhova discusses the history of the Pneumocystis pathogen, its epidemiology, and how it is transmitted to patients. She also discusses the pathophysiology of the infection in the context of the immunocompromised cancer patient. The role of steroids in the aquisition of PJP infection is touched upon. Lastly, Dr. Pasikhova describes prophylaxis against Pneumocystis, including specific agents and their usual doses.

Infections After Natural Disasters

By Shylah Moore-Pardo, MD

April 3rd, 2018

Dr. Pardo discusses the natural association of infections and natural disasters. She reflects upon events of recent history, including the 2017 hurricanes affecting Puerto Rico, the Caribbean, and the southeastern US, outbreaks after earthquakes, tornados and tsunamis. She also touches upon vector-borne diseases. Lastly, she discusses ways that infectious diseases can be prevented after natural disasters occur.

HIV Boot Camp IV: PREP for All Occasions

By Jamie Morano, MD

February 26th, 2018

Dr. Jamie Morano reviews pre-exposure prophylaxis for high-risk HIV-related exposures. She provides justification for its efficacy, its criteria for use, as well as its use in selective patient groups (e.g., heterosexuals, MSMs, serodiscordant couples, substance users). She reviews the CDC guidelines for PREP and reviews a Florida Department of Health PREP action tool kit. Presented in affiliation with the Florida Department of Health. Part IV of a four-part series.

HIV Boot Camp III: Undetectability = Untransmissability

By Jamie Morano, MD

February 26th, 2018

Dr. Jamie Morano discusses the U equals U campaign to reduce the transmissibility of human immunodeficiency virus infections by ensuring that individuals at high risk for transmission receive treatment. This has been proven to have the greatest impact in reducing to transmission of the virus to both monogamous and non-monogamous partners. This is part III in a four part series, entitled, HIV Boot Camp

Infectious Diseases Mimics and Fever

By Misbuhuddin Syed, M.D.

February 20th, 2018

Dr. Syed focuses on the diagnostic sign of fever and the ways that non-infectious factors can induce the febrile response. Dr. Syed covers neoplastic fever, central fever, neurogenic fever, autonomic dysreflexia, drug fever, periodic fever, Familial Mediterranean Fever, TRAPS, and some other less common syndromes. Dr Syed also touches on the history of how the “normal” temperature for average individuals was calculated.

Antibiotics “just In case”

By Debbie Goff, PharmD

February 9th, 2018

Have you ever taken an antibiotic “just-in-case” there might be an infection and thought antibiotics are “risk-free” drugs? Prescribing antibiotics “just-in-case” carries the risk of creating superbugs that can be resistant to every antibiotic. The overuse of antibiotics in humans and animals today means untreatable infections tomorrow. Dr. Debbie Goff pharmacist, global antibiotic steward and advocate describes how consumers and patients need to become antibiotic stewards. It is no longer just up to medical professionals. Our children’s children depend on getting everyone engaged in antibiotic stewardship. Debbie Goff Pharm.D. is an internationally renowned infectious diseases clinical pharmacist who works hand in hand with physicians and pharmacists in hospitals across six continents advocating for the responsible use of antibiotics through antibiotic stewardship. From a TedRx Columbus talk originally presented in December, 2016. Reposted with permission of the author. An IDPodcasts.net guest presentation available on our web site exclusively.

All Guts and No Glory: A Review of the Human Microbiome and Dysbiosis

By Tiffany Ward

February 5th, 2018

Dr. Tiffany Ward Looks at the ways that medical science is working to understand the significance of the human microbiome (HM), that is, the collection of all of the microorganisms that are living in association with the human body. The HM can be affected in many different ways, a phenomenon known as dysbiosis. Some of the most significant inducers of dysbiosis are diet and antimicrobial exposure. Both of these can be more closely associated than they may seem. Dr. Ward shares her perspective regarding interventions that can protect the integrity of the human microbiome, including diet, a reduction in the usage of antibiotics in the food industry, the use of probiotics, antimicrobial stewardship, and several other specific interventions.


By Adam Pettigrew, MD

January 29th, 2018

Dr. Pettigrew discusses the emerging therapeutic science of bacteriophages, viruses that infect and replicate within bacteria. Although these organisms have been utilized as antibacterial therapies for decades in some regions of the world, they are relatively unknown in western medicine. They may show promise in the treatment of resistant bacteria, as alternatives to antimicrobial compounds, in the preservation and sterilization of food products, in the defense against bioweapons and in environmental antisepsis.